Arxada AG

Formerly Lonza Specialty Ingredients, we are now Arxada - a global specialty chemicals business with leading positions in Microbial Control Solutions (MCS) and Specialty Products Solutions (SPS). We provide a broad portfolio of differentiated products targeted at a range of end markets, supported by our leading regulatory capabilities, IP expertise, and established track record in R&D.

News from this company

Chemistry & Life Sciences

Uncovering Potential

11.09.2024 -

Interview with Olivier Lambrechts, executive leadership team member and president NCE at Arxada.

News

Arxada Appoints Sanjeev Rastogi as CEO

21.09.2023 -

Arxada has appointed Sanjeev Rastogi as Chief Executive Officer (CEO), effective immediately. He succeeds Marc Doyle who led Arxada since its foundation and will join the...

Chemistry & Life Sciences

Investing in Growth Through Innovation

17.10.2022 -

Interview with Marc Doyle, CEO of Arxada, which was created following the carve-out and sale of Lonza Specialty Ingredients to private equity firms Bain Capital and...

Research & Innovation

Expert Statement: Ulrich Mayerhoeffer, Arxada

26.09.2022 -

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this...

News

Former Lonza Division LSI Rebrands as Arxada

22.10.2021 -

The former Lonza division LSI, a specialty chemicals company active in Microbial Control Solutions (MCS) and Specialty Products Solutions (SPS), will operate under the...

Contact

Arxada AG

4052 Basel
Switzerland

+41 61 316 2054